Prevpac and Glimepiride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prevpac and Glimepiride. Common interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people who take Prevpac and Glimepiride have. It is created by eHealthMe based on reports of 6 people who take Prevpac and Glimepiride from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

6 people who take Prevpac and Glimepiride together, and have interactions are studied.


What is Prevpac?

Prevpac has active ingredients of amoxicillin; clarithromycin; lansoprazole. It is often used in helicobacter pylori. eHealthMe is studying from 741 Prevpac users for its effectiveness, alternative drugs and more.

What is Glimepiride?

Glimepiride has active ingredients of glimepiride. It is often used in diabetes. eHealthMe is studying from 41,532 Glimepiride users for its effectiveness, alternative drugs and more.

Number of Prevpac and Glimepiride reports submitted per year:

Prevpac and Glimepiride drug interactions.

Common Prevpac and Glimepiride drug interactions by gender *:

female:

  1. Chronic kidney disease
  2. Biliary dyskinesia
  3. Cholelithiasis
  4. Dyskinesia
  5. Emotional disorder
  6. Extrapyramidal disorder
  7. Pancreatitis
  8. Pneumonia bacterial
  9. Sepsis
  10. Tardive dyskinesia

male:

  1. Chronic kidney disease
  2. Gastrooesophageal reflux disease
  3. Renal failure
  4. Renal impairment
  5. Electrocardiogram qt prolonged
  6. Gastric ulcer
  7. Gastrointestinal haemorrhage
  8. Syncope
  9. Thrombocytopenia
  10. Nephrogenic anaemia

Common Prevpac and Glimepiride drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Biliary dyskinesia
  2. Cholelithiasis
  3. Pancreatitis
  4. Pneumonia bacterial

50-59:

  1. Gastrooesophageal reflux disease
  2. Nephrogenic anaemia
  3. Renal failure
  4. Renal impairment
  5. Chronic kidney disease

60+:

  1. Electrocardiogram qt prolonged
  2. Gastric ulcer
  3. Gastrointestinal haemorrhage
  4. Syncope
  5. Thrombocytopenia
  6. Chronic kidney disease
  7. Gastrooesophageal reflux disease
  8. Renal failure
  9. Renal impairment

* Approximation only. Some reports may have incomplete information.

Do you take Prevpac and Glimepiride?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Prevpac and Glimepiride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Prevpac interactions:

Browse all interactions between Prevpac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Glimepiride interactions:

Browse all interactions between Glimepiride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amoxicillin; clarithromycin; lansoprazole and glimepiride (the active ingredients of Prevpac and Glimepiride, respectively), and Prevpac and Glimepiride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Prevpac and Glimepiride.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: